Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Pediatric Neurology Briefs Publishers
2011-05-01
|
| Edice: | Pediatric Neurology Briefs |
| Témata: | |
| On-line přístup: | https://www.pediatricneurologybriefs.com/articles/632 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|